Related search

In Vitro Antiviral Profile of Ruzasvir: A Potent and Pan-Genotype Inhibitor of HCV NS5A

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

The Efficacy and Safety of Elbasvir/Grazoprevir Treatment in HCV Genotype 1 Patients in Taiwan

Journal of Medical Virology
VirologyInfectious Diseases
2019English

Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial

Hepatology
MedicineHepatology
2018English

Perilipin 5 Alleviates HCV NS5A-induced Lipotoxic Injuries in Liver

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2019English

Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

Gastroenterology
HepatologyGastroenterology
2019English

NS5A-P32 Deletion After Failure of Ledipasvir/Sofosbuvir in Hepatitis C Virus Genotype 1b Infection

Hepatology
MedicineHepatology
2018English

Heart Failure After Treatment for Breast Cancer

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2020English

Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Late‐onset Heart Failure After Treatment for Breast Cancer

Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy